Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

Core Viewpoint - Sanara MedTech Inc. is focused on developing transformative medical technologies aimed at improving clinical outcomes and reducing healthcare costs in surgical, chronic wound, and skincare markets [3]. Group 1: Company Overview - Sanara MedTech Inc. is based in Fort Worth, Texas, and is publicly traded on Nasdaq under the ticker SMTI [1]. - The company specializes in surgical, wound, and skincare products, which are marketed and distributed primarily in North America [3]. - Key products include CellerateRX® Surgical Activated Collagen, FORTIFY TRG® Tissue Repair Graft, and various antimicrobial wound care solutions [3]. Group 2: Upcoming Events - Ron Nixon, the Chairman and CEO of Sanara, will present at the Piper Sandler 36th Annual Healthcare Conference from December 3 to 5, 2024, with his presentation scheduled for December 4 at approximately 11:50 a.m. Eastern Time [1]. - Presentation materials will be available on the company's investor relations website prior to the event, and a live audio webcast will also be accessible [2]. Group 3: Product Pipeline and Strategy - Sanara's pipeline includes innovative product candidates aimed at addressing opportunistic pathogens, wound healing, and tissue debridement [3]. - The company is committed to forming long-term strategic partnerships to enhance product outcomes while lowering overall costs [3].